C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 7/01 (2006.01) A61K 39/12 (2006.01) A61K 39/15 (2006.01) C12N 7/00 (2006.01) C12N 7/04 (2006.01) C12N 15/33 (2006.01) C12N 15/40 (2006.01) C12N 15/86 (2006.01) G01N 33/50 (2006.01) G01N 33/569 (2006.01)
Patent
CA 2238659
The present invention provides a birnavirus mutant which is suited as vaccine candidate in eradication control programmes. The mutant is not able to produce a native VP5 protein, and this feature can be used as a marker to distinguish between animals vaccinated with the VP5 mutant or infected with a naturally-occurring birnavirus.
La présente invention porte sur un mutant du birnavirus qui peut être utilisé comme candidat- vaccin dans le cadre de programmes d'éradication de maladies. Le mutant est incapable de produire une protéine native du gène VP5, et cette caractéristique peut être utilisée comme marqueur afin de distinguer les animaux vaccinés avec le mutant du gène VP5 des animaux infectés par un birnavirus naturel.
Lutticken Heinrich Dieter
Mundt Egbert
Van Loon Adriaan Anthonius Wilhelmus Maria
Akzo Nobel N.v.
Fetherstonhaugh & Co.
Intervet International B.v.
LandOfFree
Recombinant birnavirus vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant birnavirus vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant birnavirus vaccine will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1714424